Linio Biotech

📍 Helsinki, Finland🗓 Founded 2017👥 20 employees💰 Last funded May 2024
Biotechnology Research🌐 linio-biotech.com
Website LinkedIn
Linio Biotech is a biotechnology platform company dedicated to developing novel solutions that significantly improve the lives of people suffering from skin defects and aging skin. World’s first cell-free tissue product, Tience®, for tissue regeneration is a result of more than a decade of research and development and will challenge the market for regenerative aesthetics. Our driven and competent international team is committed to taking this new core technology to the global market.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
2
Frequently asked questions
Who invested in Linio Biotech?
Linio Biotech has 2 investors on record on gritt.io and 2 late-stage investors.
When did Linio Biotech last raise funding?
The most recent investment in Linio Biotech recorded on gritt.io was in May 2024.
When was Linio Biotech founded?
Linio Biotech was founded in 2017.
What industry is Linio Biotech in?
Linio Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Linio Biotech based?
Linio Biotech is headquartered in Helsinki, Finland.